During the past decade, Pusan National University Hospital conducted 316 clinical trials. In the 10-year time frame, 316 clinical trials started and 79 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 146 clinical trials started and 55 clinical trials were completed. i.e. 37.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pusan National University Hospital" #1 sponsor was "Pusan National University Yangsan Hospital" with 41 trials, followed by "Hoffmann-La Roche" with 28 trials sponsored, "Pusan National University Hospital" with 27 trials sponsored, "Seung-Jung Park" with 19 trials sponsored and "Pfizer" with 19 trials sponsored. Other sponsors include 261 different institutions and companies that sponsored additional 145 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pusan National University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 24 trials as a collaborator, "Pusan National University Hospital" with 6 trials as a collaborator, "Abbott" with 4 trials as a collaborator, "Chonnam National University Hospital" with 4 trials as a collaborator and "Kyungpook National University Hospital" with 4 trials as a collaborator. Other collaborators include 150 different institutions and companies that were collaborators in the rest 122 trials.

According to Clinical.Site data, the most researched conditions in "Pusan National University Hospital" are "Coronary Artery Disease" (23 trials), "Chronic Hepatitis B" (9 trials), "Crohn's Disease" (9 trials), "Ulcerative Colitis" (9 trials) and "Crohn Disease" (8 trials). Many other conditions were trialed in "Pusan National University Hospital" in a lesser frequency.

Most popular intervention types in "Pusan National University Hospital" are "Drug" (250 trials), "Device" (46 trials), "Other" (42 trials), "Biological" (28 trials) and "Dietary Supplement" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (71 trials), "Placebo group" (10 trials), "Rituximab" (6 trials), "Sham Procedure" (6 trials) and "Oxaliplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Pusan National University Hospital" are 371 trials for "All" genders, 19 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Pusan National University Hospital". undefined are not yet recruiting, 89 are recruiting, 59 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 175 completed trials in Pusan National University Hospital, undefined suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Pusan National University Hospital, 24 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 136 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 40 trials, and there were also 56 trials that are defined as “Not Applicable".